News

Hosted on MSN7mon

PoNS therapy shows promise for MS gait deficits

NEWTOWN, Pa. - Helius Medical Technologies, Inc. (NASDAQ:HSDT), a neurotech company with a market capitalization of $3.84 million, announced significant findings from the PoNS Therapeutic Experience ...
The American Journal of Managed Care7y

Study Uses Algorithms to Improve Gait Monitoring Treatments for MS

A recent study looked to improve the monitoring of treatments for patients with multiple sclerosis (MS) by quantifying gait characteristics and gait deficits in laboratory and daily life conditions. A ...
Healio1y

Patient-recorded home video feasible method to assess gait kinematics in MS

Please provide your email address to receive an email when new articles are posted on . Adults with MS took home videos of themselves walking and uploaded them to a digital platform. Video taken in ...
News Medical4y

FDA authorizes marketing of new device for short-term treatment of gait deficit in MS patients

Today, the U.S. Food and Drug Administration authorized marketing of a new device indicated for use as a short-term treatment of gait deficit due to mild to moderate symptoms from multiple sclerosis ...
Yahoo Finance7mon

Helius Medical Technologies, Inc. Announces First Clinical Evidence of Positive Long-term Therapeutic Effects of PoNS Therapy® on Gait Deficit Improvement in Multiple ...

NEWTOWN, Pa., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic ...